The proof is in the data

Twist Biopharma is a trusted partner with a proven track record for developing superior antibody leads with drug like developability profiles

Discovering High-Affinity, Functional Anti-GPCR Antibodies

Read how Twist’s Synthetic Libraries were designed and used to identify GLP-1R antagonistic antibodies.

Read the app note now

Achieving large-scale antibody affinity maturation

Learn how the Twist Antibody Optimization (TAO) service dramatically improved the affinity of an anti-PD1 antibody.

Read the article now

Candidates recapitulated Beacon binding profiles as recombinantly expressed antibodies

Read about rapid discovery of rare, specific antibodies against a cell surface target.

Read the case study now

Deep analysis allows for the final selection of leads using epitope binning and neutralization data

Read about enhanced epitopic coverage with a diverse range of affinity via DiversimAb and humanzied mice.

Read the case study now

Start here

One of our sales experts will get back to you shortly